Nov 15, 2024 / 03:00PM GMT
Operator
Greetings. Welcome to Trinity Biotech's third-quarter 2024 earnings conference call. (Operator instructions) As a reminder, this conference is being recorded.
It is now my pleasure to introduce Eric Ribner, Investor Relations. Thank you, Eric, you may begin.
Eric Ribner - Trinity Biotech PLC - Managing Director
Thanks very much. Before we begin, please note that statements made during this presentation may be deemed forward-looking statements within the meaning of Federal Securities Laws. These statements are subject to known and unknown risks and uncertainties that may cause actual events to differ from those expressed or implied in such statements.
These risks include, but are not limited to those set forth in the risk factor statement in the company's annual report on Form 20-F filed with the SEC. Trinity Biotech undertakes no obligations to publicly update or revise these forward-looking statements to reflect events or circumstances after today or the occurrence of unanticipated events.
I will now hand you over to John Gillard,
Q3 2024 Trinity Biotech PLC Earnings Call Transcript
Nov 15, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers